Search references for GLP. Phrases containing GLP
See searches and references containing GLP!GLP
Gastrointestinal peptide hormone involved in glucose homeostasis
Glucagon-like peptide-1 (GLP-1) is a peptide hormone produced by cleavage of proglucagon and secreted by the gastrointestinal tract, pancreas, and specific
Glucagon-like_peptide-1
Class of anti-diabetic and anti-obesity medication
(GLP-1) receptor agonists, also known as GLP-1 agonists, GLP-1RAs, and informally as simply GLP-1s, are a class of medications that activate the GLP-1
GLP-1_receptor_agonist
Topics referred to by the same term
GLP or glp in Wiktionary, the free dictionary. GLP or glp may refer to: Glucagon-like peptide-1 (GLP-1) GLP-1 receptor agonists, also known as "GLPs"
GLP
Singaporean logistics provider
GLP (formerly Global Logistic Properties) is a global owner, developer and operator of logistics real estate, digital infrastructure and renewable energy
GLP_(company)
Anti-diabetic and anti-obesity medication
Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist. It is used as an antidiabetic medication to treat type 2 diabetes
Tirzepatide
Anti-diabetic and anti-obesity medication
similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain, and acts as a GLP-1 receptor agonist. The most common side effects
Semaglutide
Receptor activated by peptide hormone GLP-1
that binds the C-terminal helix of GLP-1, and one transmembrane domain (TMD) that binds the N-terminal region of GLP-1. In the TMD domain a fulcrum of
Glucagon-like peptide-1 receptor
Glucagon-like_peptide-1_receptor
Chemical compound
company Eli Lilly and Company. It is a triple hormone receptor agonist on the GLP-1, GIP, and glucagon receptors. The safety profile of retatrutide is still
Retatrutide
Peptide hormone in humans
a number of active hormones such as glucagon, GLP-1, or GLP-2, depending on the tissue. GLP-2 (and GLP-1) in particular are produced and secreted by the
Glucagon-like_peptide-2
Drugs that lower blood glucose levels to treat diabetes
peptide (GLP) agonists bind to a membrane GLP receptor. As a consequence, insulin release from the pancreatic beta cells is increased. Endogenous GLP has a
Diabetes_medication
(GLP) a lab quality standard
The Principles of Good Laboratory Practice (GLP) establish rules and criteria for a quality system that oversees the organizational processes and conditions
Good_laboratory_practice
Group of gastrointestinal hormones
of Langerhans by a blood-glucose–dependent mechanism. Incretins such as GLP-1 inhibit glucagon release from the alpha cells of the islets of Langerhans
Incretin
Class of drugs used to treat diabetes
including the glucagon-like peptide-1 (GLP-1) receptor. These drugs are developed for the same indications as GLP-1 receptor agonists—especially obesity
GLP1_poly-agonist_peptides
Anti-obesity medication
medication used for weight management. It is an oral, non-peptide, small-molecule GLP-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company
Orforglipron
Chief Financial Officer of Alphabet Inc.
Ashkenazi's tenureship as CFO, Eli Lilly successfully introduced a line of GLP-1 agonists based on tirzepatide under the brand names Mounjaro and Zepbound
Anat_Ashkenazi
as both the GLP and Greens gained over five percentage points in the Cantonal Council. The parties of the loose "Climate Alliance" (SP, GLP, Greens, EVP
2023 Zürich cantonal elections
2023_Zürich_cantonal_elections
Swiss-based think tank
The glp lab is a think tank of the Green Liberal Party of Switzerland. Corina Liebi has been its president since 2022. The lab was established in 2016
Glp_lab
American telehealth company
its Body Program. In May 2024, in response to continual GLP-1 supply shortages, Ro launched a GLP-1 Supply Tracker to help people crowdsource information
Ro_(company)
Danish scientist (born 1964)
glucagon-like peptide-1 (GLP-1), a hormone that stimulates the production of insulin but has a short half-life of minutes in the body. GLP-1 had been previously
Lotte_Bjerre_Knudsen
Class of pharmacological agents
earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss. As of 2023, the medications
Anti-obesity_medication
Canadian endocrinologist (born 1956)
discoveries of the biological actions of glucagon-like peptides GLP-1 and GLP-2, including GLP-1's key role in stimulating glucose-dependent insulin secretion
Daniel_J._Drucker
Bosnian born Swiss politician
announced her resignation from the leadership of the Zurich GLP on 9 September. On the same day, the GLP Switzerland announced that it would initiate expulsion
Sanija_Ameti
American telehealth company
compounded injectable semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1) prescription treatment, as part of a new weight-loss specialty on its
Hims_&_Hers_Health
American metabolic disease treatment company
preclinical development to enable the pancreas to produce glucagon-like peptide-1 (GLP-1). Harith Rajagopalan, MD, PhD, and Jay Caplan established Fractyl Health
Fractyl_Health
Swiss political party
Green Liberal Party of Switzerland (German: Grünliberale Partei der Schweiz, GLP; Romansh: Partida verda-liberala, PVL; French: Parti vert'libéral, PVL; Italian:
Green Liberal Party of Switzerland
Green_Liberal_Party_of_Switzerland
Pharmaceutical compound
developmental code name LY-3537031) is a dual agonist of glucagon-like peptide-1 (GLP-1) receptors and gastric inhibitory polypeptide (GIP) receptors. Brenipatide
Brenipatide
Anti-diabetic medication
under the skin. Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. It works by increasing
Liraglutide
Protein-coding gene in the species Homo sapiens
Glucagon-like peptide-2 receptor (GLP-2R) is a protein that in human is encoded by the GLP2R gene located on chromosome 17. The GLP2 receptor (GLP2R)
Glucagon-like peptide-2 receptor
Glucagon-like_peptide-2_receptor
Experimental medication
developed by Amgen for the treatment of obesity. It is an agonist of the GLP-1 receptor (GLP-1R) and an antagonist of the glucose-dependent insulinotropic polypeptide
Maridebart_cafraglutide
The Government Legal Profession (GLP), formerly the Government Legal Service, is an umbrella group comprising around two thousand qualified lawyers working
Government_Legal_Profession
Macedonian American chemist
Yugoslav-born, Macedonian American chemist whose study of glucagon-like peptide-1 (GLP-1) led to her uncovering its role in glucose metabolism and the secretion
Svetlana_Mojsov
Chemical compound
Aleniglipron (development code GSBR-1290) is a small-molecule GLP-1 agonist developed by Structure Therapeutics. It is delivered orally and is in a Phase
Aleniglipron
Danish physician and physiologist (born 1955)
reported that intravenous infusion of GLP-1 increased satiety and reduced food intake in healthy men, and concluded that GLP-1 may play a physiological role
Arne_Astrup
Medication
39-amino-acid analogue of human glucagon-like peptide-2 (GLP-2). Its structure consistist of the 33-residue GLP-2 backbone with nine amino-acid substitutions and
Glepaglutide
School in Cheonan, South Korea
and Na Ju-hwan. Bugil Academy's Global Leader Program (GLP) is a "school within a school". The GLP comprises students in the three grades (10–12) of class
Bugil_High_School
SVP, 2 FDP, 1 SP, 1 GLP, 1 DM 2 SVP, 1 FDP, 2 SP, 1 DM, 1 GLP 2 SVP, 2 FDP, 2 SP, 1 GLP 2 SVP, 1 FDP, 1 SP, 1 DM, 1 Grüne, 1 GLP 3 Right (SVP, FDP), 4
Opinion polling for the 2023 Swiss federal election
Opinion_polling_for_the_2023_Swiss_federal_election
Chinese alternative investment firm
is currently a joint venture (JV) between China Merchants Group (CMG) and GLP. In June 2021, Private Equity International ranked CMC as the largest private
China_Merchants_Capital
GLP-1 receptor agonist and amylin receptor agonist
Amycretin/Zenagamtide (development code NN 9487) is a single molecule that operates as a GLP-1 receptor agonist and amylin receptor agonist. It is under development by
Zenagamtide
Enzyme blocker and diabetes treatment drug
levels. The mechanism of DPP-4 inhibitors is to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin
Dipeptidyl peptidase-4 inhibitor
Dipeptidyl_peptidase-4_inhibitor
Peptide drug
experimental peptide that works as a dual glucagon/GLP-1 receptor agonist. Unlike other dual GLP-1/glucagon dual agonists, it is a glucagon analog rather
Survodutide
Protein-coding gene in the species Homo sapiens
Euchromatic histone-lysine N-methyltransferase 1, also known as G9a-like protein (GLP), is a protein that in humans is encoded by the EHMT1 gene. EHMT1 messenger
EHMT1
Governor of Illinois since 2019
politician as of 2025. On September 21, 2026, Pritzker said he had been taking a GLP-1 drug for about two years to lose weight and control his blood sugar level
JB_Pritzker
Swiss parliamentary group (2007–2011)
The Christian Democrats/EVP/glp Group (German: Fraktion CVP/EVP/glp, French: Groupe PDC-PEV-PVL, Italian: PPD-PEV-glp), abbreviated to CEg, was a centrist
Christian Democrats/EVP/glp Group
Christian_Democrats/EVP/glp_Group
Largest species of lizard in the United States
peptides; one of these, exendin-4, formed the basis for the development of the GLP-1 receptor agonists, used to treat type 2 diabetes and obesity. The name
Gila_monster
Pharmaceutical compound
Nonproprietary Name; developmental code name HDM1002) is a glucagon-like peptide-1 (GLP-1) receptor agonist which is under development for the treatment of type
Conveglipron
German motorsport event series
Nordschleife version, on Saturday afternoon following a Gleichmäßigkeitsprüfung (GLP) run by the same organizing club. One or two additional events are held on
Rundstrecken Challenge Nürburgring
Rundstrecken_Challenge_Nürburgring
Private school in Seoul, South Korea
Global Leadership Program (GLP), a special academic block scheduling course intended to prepare students for colleges abroad. GLP courses are centered on
Daewon Foreign Language High School
Daewon_Foreign_Language_High_School
Experimental drug
MDR-001 is an experimental GLP-1 receptor agonist that is delivered orally. JI, LINONG; GAO, LEILI; ZHOU, LI HUA; CAI, HANQING; ZENG, JUN; ZHAO, YUZHU;
MDR-001
Diabetes medication
breaks down the incretins GLP-1 and GIP, gastrointestinal hormones released in response to a meal. By preventing breakdown of GLP-1 and GIP, they are able
Sitagliptin
Danish businessperson
within diabetes, obesity and biopharmaceuticals. He led the development of GLP-1 therapies that today are among the leading treatments within type 2 diabetes
Mads_Krogsgaard_Thomsen
Danish physician and physiologist (born 1945)
known for discovering and describing the hormone glucagon-like peptide-1 (GLP-1), a hormone in the gut that plays an important role in the onset and development
Jens_Juul_Holst
Combination drug
cagrilintide, a dual amylin and calcitonin receptor agonist, and semaglutide, a GLP-1 agonist. It has been proposed as a follow-on to semaglutide (alone) or
Cagrilintide/semaglutide
Chemical compound
class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta
Vildagliptin
Neologism from online manosphere communities
of human testing with this peptide. GLP-1 is another common peptide in the looksmaxxing sphere. The effects of GLP-1 have been researched to improve conditions
Looksmaxxing
Chemical compound
Dapiglutide (formerly ZP 7570) is a dual GLP-1 and GLP-2 receptor agonist developed by Zealand Pharma. It is a peptide with a main chain of 33 amino acid
Dapiglutide
August 2012). The organization has referred to these competitive rounds as GLP 1.0, 2.0, and 2.5. There will likely be further rounds of funding for environmentally
Green_Launching_Pad
Swiss lawyer and politician
elected to the Swiss National Council on the ticket of Green Liberal Party (GLP) in 2019. Christ was raised in Oberwil and studied Law at the University
Katja_Christ
Japaridze's polymodal logic (GLP) is a system of provability logic with infinitely many provability modalities. This system has played an important role
Japaridze's_polymodal_logic
Chemical compound
Pemvidutide is an experimental dual GLP-1/glucagon receptor agonist for the treatment of MASH, obesity, AUD, and ALD developed by Altimmune, a clinical-stage
Pemvidutide
Official accreditation body for South Africa
testing scheme providers Good Laboratory Practice (GLP) test facilities for compliance to OECD GLP principles SANAS is located on the Department of Trade
South African National Accreditation System
South_African_National_Accreditation_System
American entrepreneur, investor, and CEO of Hims & Hers Health
January 2021 under the ticker NYSE: HIMS. In 2024, Hims & Hers expanded into GLP-1 weight loss medicine and generated annual revenues of $1.48 billion. Andrew
Andrew_Dudum
American internet personality
compiling charts on what he calls the "Black-White IQ gap", and discussing GLP-1 receptor agonists. He has been associated with natalism. In 2019, Lasker
Jordan_Lasker
Medication
unclear safety. Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. It works by increasing
Exenatide
Persistent and intrusive thoughts about food
increased markedly in 2022, possibly due to the rising use of GLP-1 receptor agonist drugs (GLP-1 RA drugs) for weight loss. Growing public interest spurred
Food_noise
Pharmaceutical compound
Efinopegdutide (MK-6024) is a dual agonist of the glucagon and GLP-1 receptors. It is being developed by Merck for non-alcoholic fatty liver disease.
Efinopegdutide
Mammalian protein found in Homo sapiens
to stimulate insulin secretion. GIP, along with glucagon-like peptide-1 (GLP-1), belongs to a class of molecules (incretins) which stimulate insulin release
Gastric inhibitory polypeptide
Gastric_inhibitory_polypeptide
Diabetes medication
peptide-1 receptor agonist (GLP-1 agonist) consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4. GLP-1 is a hormone that is involved
Dulaglutide
Antidiabetic medication
Administration (FDA). 21 February 2023. Retrieved 14 March 2024. Patel AS (2025). "GLP-1 (RT) 10mg (Retatrutide): Triple Receptor Agonist for Metabolic Research"
Bexagliflozin
Casino in Maryland, United States
casino in Perryville, Maryland, owned by Gaming and Leisure Properties (GLP) and operated by Penn Entertainment. It was the first casino to open in the
Hollywood_Casino_Perryville
Pharmaceutical compound
of both the glucagon receptor and the glucagon-like peptide-1 receptor (GLP-1). It was originally developed as a potential treatment for diabetes but
PF-06372222
Long-acting insulin
poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins")
Insulin_glargine
Diabetes medication
poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins")
Empagliflozin
Experimental drug
Ecnoglutide (XW003) is a GLP-1 agonist being developed for the treatment of obesity and type 2 diabetes. In preclinical trials, "Ecnoglutide showed a
Ecnoglutide
American pharmaceutical company
Lilly brought exenatide to market—the first of the GLP-1 receptor agonists—followed by the GIP and GLP-1 receptor agonist drugs Mounjaro and Zepbound (tirzepatide)
Eli_Lilly_and_Company
Rapid-acting man-made insulin
poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins")
Insulin_aspart
Pharmaceutical drug
Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline (GSK) for treatment of type 2
Albiglutide
American endocrinologist (1937–2025)
of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2). He was awarded the 2020 Warren Alpert Foundation Prize
Joel_Habener
Chemical compound
development by Merck & Co. It inhibits DPP-4 to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin
Omarigliptin
Casino hotel in Missouri, United States
Properties (GLP), while Eldorado Resorts (now Caesars Entertainment) would buy Tropicana's operating business and lease its properties from GLP. The deal
Horseshoe_St._Louis
Class of medication
systematic review and network meta-analysis comparing SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors demonstrated that use of SGLT2 inhibitors
SGLT2_inhibitor
Public university in Sydney, New South Wales, Australia
successful completion of the GLP, students receive a formal notation on their academic transcript and a certificate. Macquarie's GLP was the first of its kind
Macquarie_University
American influencer, model, and reality show cast member
"'Mormon Wives' Star Layla Taylor Shares Dark Details of Modeling Days Before GLP-1s". The Looker. 2026-04-22. Archived from the original on 2026-06-30. Retrieved
Layla_Taylor
State of being filled or satisfied
multiple substances that affect digestion and satiety. Glucagon-like peptide-1 (GLP-1) is an incretin released by the duodenum that inhibits relaxation of the
Satiety
Diabetes drug
Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes. Lixisenatide is
Lixisenatide
Class of organic compounds used in medicine and agriculture
poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins")
Sulfonylurea
Turkish politician (born 1977)
driving teacher and a politician of the Green Liberal Party of Switzerland (GLP). He is the president of the Grand Council of Basel. Bülent Pekerman was
Bülent_Pekerman
Swiss politician (born 1979)
6 April 1979) is an educator and politician of the Green Liberal Party (GLP). Since 2007 she is a member of the National Council and since 2011 she is
Tiana_Angelina_Moser
American actor (born 1976)
Glutton. In August 2026, Suplee publicly cautioned against overreliance on GLP-1 weight-loss drugs, saying that sustainable weight loss comes from building
Ethan_Suplee
Malignancy originating in the thyroid gland
package inserts of GLP-1 agonists due to the risk of thyroid C-cell tumors, including medullary thyroid cancer (MTC), with a warning that GLP-1 agonists are
Thyroid_cancer
Pharmaceutical compound
permanently increase nutrient-responsive secretion glucagon-like peptide-1 (GLP-1) by pancreatic β-cells. The therapy is administered via a 25-gauge needle
Rejuva
Combination drug
icodec, a basal insulin analog; and semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist. Insulin icodec regulates glucose metabolism by binding
Insulin_icodec/semaglutide
Pharmaceutical compound
a functional antagonist of the glucagon-like peptide-1 receptor (GLP-1). While GLP-1 receptor agonists are widely used for the treatment of obesity and
HTL26119
Pharmaceutical compound
Efpeglenatide is a GLP-1 receptor agonist under development for the treatment of type 2 diabetes and obesity and reducing the risk of cardiovascular incidents
Efpeglenatide
Diabetes medication
poly-agonist peptides Mazdutide (GLP-1/GCGR) Retatrutide§ (GLP-1/GIP/GCGR) Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins")
Dapagliflozin
System for powering electric vehicles
Ground-level power supply, also known as surface current collection or, in French, alimentation par le sol ("feeding via the ground"), is a concept and
Ground-level_power_supply
Short chains of 2–50 amino acids
Ghrelin Duodenum CCK GIP Secretin Motilin VIP Ileum Enteroglucagon Peptide YY GLP-1 Liver/other Insulin-like growth factor IGF-1 IGF-2 Adipose tissue Leptin
Peptide
Inability to feel pleasure
broader neuropsychiatric benefits. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have shown promise in treating anhedonia by modulating dopaminergic
Anhedonia
Swiss medical technology company
demand for SHL’s drug delivery devices increased alongside the growing use of GLP-1 receptor agonist therapies such as Ozempic and Wegovy. By 2024, Forbes
SHL_Medical
Swiss politician
21 January 1965) is a Swiss politician (GLP). Flach was one of the founding members of the cantonal Aargau GLP in 2008. On 8 March 2009 he was elected
Beat_Flach
Sale of products directly to customers bypassing middlemen
industry, strong demand for anti-obesity medications following the rise of GLP-1 drugs prompted Eli Lilly and Novo Nordisk to develop direct-to-consumer
Direct-to-consumer
travel, tourism, insurance
GLP
GLP
GLP
GLP
GLP
GLP
GLP
GLP
GLP
travel, tourism, insurance